Search Articles
Filter Articles
Found 1,803 articles
Top Pharma and Life Science organisations hiring in June
- 7 Jun 2022
Here's a list of the top pharma and life science companies hiring in June on PharmiWeb.jobs
Akili Announces Veteran Life Sciences Executive Matt Franklin in Newly Created Role of President and Chief Operating Officer
- 7 Jun 2022
Akili Interactive (“Akili”), a leading digital medicine company pioneering the development of cognitive treatments through game-changing technologies, today announced that industry veteran Matt Franklin will join the company in the newly created role of President and Chief Operating Officer, effective June 21, 2022.
ProBioGen Grows by 50 Percent in Last Two Years
- 7 Jun 2022
The Berlin-based biopharmaceutical enterprise ProBioGen has increased its staff by 50 percent since April 2020. More than 250 "ProBioGeniuses", as employees are known internally, now work in the company's three locations in Berlin. Reflecting this growth, ProBioGen has filled two strategic important positions.
Coriolis Pharma Invests in Growth by Creating a New Campus in Martinsried-Munich
- 7 Jun 2022
Coriolis Pharma, a globally operating contract research and development organization (CRDO) and one of the world leaders in formulation research and development of (bio)pharmaceutical drugs, ATMP´s and vaccines, is expanding its current headquarters to form a new Campus as the next step in its growth strategy.
The Latest Features and News from PharmiWeb.Jobs
- 7 Jun 2022
It’s been a busy few years at PharmiWeb as we continue our growth on a global scale. After establishing ourselves as a leading Life Science job board, we have been focused on developing our entire range of Talent Acquisition solutions, introducing new features and resources to help our clients continue to locate and engage the best talent in the industry.
-
Tetra Bio-Pharma Opens New Subsidiary in Australia and Provides Regulatory Update
- 7 Jun 2022
Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and development announces the launch of its new wholly owned subsidiary 'Tetra Bio-Pharma Australia Pty Ltd' ("TBP-AU"), an Australian-based research company focused on the execution of clinical trials in Australia.
TIACA Welcomes Two New Members to the Board of Directors
- 6 Jun 2022
The International Air Cargo Association (TIACA) announced that two new members have been appointed to serve on the Board of Directors creating one of the most diverse Boards in our history.
GSK announces US FDA approval of Priorix for the prevention of measles, mumps and rubella in individuals 12 months of age and older
- 6 Jun 2022
GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Priorix (Measles, Mumps and Rubella Vaccine, Live) for active immunisation for the prevention of measles, mumps and rubella (MMR) in individuals 12 months of age and older.
Samanta Cimitan Appointed Chief Business Officer at Celonic
- 1 Jun 2022
Celonic Group, a Swiss-German contract development and manufacturing organization (CDMO), has appointed Dr. Samanta Cimitan as the Chief Business Officer (CBO) of Celonic Group.
Tobias Hauser joins Limbic as Head of Computational Psychiatry
- 1 Jun 2022
Hauser has worked at the intersection of psychiatry, neuroscience and artificial intelligence and is one of the leaders in the field of cognitive neuroscience and computational psychiatry.
Top Pharma and Life Science Events in June 2022
- 1 Jun 2022
15 Pharma and Life Science events taking place in June 2022, including Pharmaceutical, Biotechnology, Clinical Research and Medical Devices events.
Novavax Initiates Phase 3 Trial of its COVID-19 Omicron Strain Vaccine as a Booster
- 1 Jun 2022
Novavax today announced the initiation of its Phase 3 strain change trial to determine if its Omicron variant specific vaccine, NVX-CoV2515 (Omicron BA.1 strain), induces superior antibody responses against the Omicron variant compared to its Wuhan prototype vaccine, NVX-CoV2373, in participants who have received either a primary (two doses) or booster (three doses) series of an mRNA vaccine.
Abbott FreeStyle Libre® 3 Receives U.S. FDA Clearance - Features World's Smallest, Thinnest and Most Accurate 14-Day Glucose Sensor
- 1 Jun 2022
Abbott (NYSE: ABT) today announced the U.S. Food and Drug Administration (FDA) cleared its next-generation FreeStyle Libre 3 system for use by people four years and older6 living with diabetes.
Antev Appoints Steven van Os as Chief Medical Officer
- 31 May 2022
Antev Ltd., a company focused on developing its GnRH1 Antagonist, teverelix, in lead indication of Advanced Prostate Cancer, is delighted to announce the appointment of Dr Steven van Os as Chief Medical Officer. He joins the executive management team with responsibility for the development of the company´s clinical portfolio in men’s health.
Regeneron Completes Acquisition of Checkmate Pharmaceuticals
- 31 May 2022
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it has successfully acquired Checkmate Pharmaceuticals, Inc., deepening its commitment to immuno-oncology and adding a new modality to the company's portfolio of potential combination-ready approaches for difficult-to-treat cancers.
Evotec adds cell therapy manufacturing facility with acquisition of Rigenerand
- 30 May 2022
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced the signing of a definitive agreement under which Evotec will acquire 100% of the capital of Rigenerand Srl, a leading cell technology company, for a purchase price of € 23 m. Founded in 2009 as a spin-off of the University of Modena and Reggio Emilia, Rigenerand is a pioneering company in the field of cGMP manufacturing of cell therapies.
GSK announces further appointments to Designate Haleon Board
- 30 May 2022
GSK plc (LSE/NYSE: GSK) has today announced the appointments of Asmita Dubey, Marie-Anne Aymerich and Bryan Supran to the Designate Haleon Board, the new independent company to be formed following the demerger of the GSK Consumer Healthcare business, expected in July 2022.
Syneos Health Names Michelle Keefe as Next Chief Executive Officer
- 30 May 2022
Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the appointment of Michelle Keefe as CEO and a member of the Company’s Board of Directors. Keefe, currently President, Medical Affairs and Commercial Solutions, succeeds Alistair Macdonald, who will retire after 20 years at Syneos Health.
13 Ways to Reduce Employee Burnout
- 30 May 2022
In the workplace, burnout can have a huge impact on employee engagement, leading to low productivity and high staff turnover. On the flip side, effectively preventing burnout can improve employee retention and help to attract future talent. This article outlines 13 ways Life Science employers can reduce employee burnout; from writing a descriptive and well-thought-out job description to redesigning the physical workplace.
Petrichor Managing Partner Tadd Wessel Joins the ICPO Foundation Board of Curators
- 27 May 2022
The International Centers for Precision Oncology (ICPO) Foundation is pleased to announce new support from Petrichor Healthcare Capital Management (Petrichor) and the appointment of Tadd Wessel, Petrichor’s Founder and Managing Partner, to the ICPO Board of Curators.
